Massive things going forward for this company, most notably the seismic shift in how the FDA will approve AD drugs for use, and a BoD who understand the way to use this shift.
- Forums
- ASX - By Stock
- ACW
- Ann: Actinogen Ethics Committee approval for XanaMIA study
Ann: Actinogen Ethics Committee approval for XanaMIA study, page-42
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
8.5¢ | 8.8¢ | 8.4¢ | $523.2K | 6.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 246627 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 98651 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 246627 | 0.084 |
1 | 24096 | 0.083 |
5 | 176000 | 0.082 |
3 | 151000 | 0.081 |
4 | 426250 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 98651 | 3 |
0.086 | 236392 | 3 |
0.087 | 44646 | 2 |
0.088 | 379517 | 5 |
0.089 | 490158 | 7 |
Last trade - 13.12pm 29/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |